Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Study: artificial intelligence matches/outperforms ophthalmologists ➤ Primary endpoint met in Phase 3 trial using an antibody to treat thyroid eye disease ➤ FDA grants Breakthrough Device Designation to novel spectacle design ➤ ASCRS news and events
➤ FDA approves IND for neuropathic pain drug ➤ Phase 2 preliminary efficacy and safety data for wet AMD treatment trial ➤ First-in-human data for DME, AMD therapy ➤ Study: Rapid eye stroke detection protocol helps prevent vision loss ➤ Enrollment complete for Phase 3 trial for sozinibercept ➤ ASCRS news and events
➤ FDA warns against copycat eye drops ➤ Generic drop receives FDA approval ➤ Topline data revealed in two presentations ➤ New 72-week data from Phase 3 RVO treatment studies ➤ First patient dosed in Phase 2/3 trial for GA treatment ➤ ASCRS news and events
➤ FDA approves first IND for RNA exon editor ➤ SPA granted for Phase 3 trial of an intravitreal implant for wet AMD ➤ Study: retinal imaging helps predict risk of developing a host of diseases ➤ European Medicines Agency recommends rejection of pegcetacoplan for GA ➤ ASCRS news and events
➤ FDA agrees to special protocol assessment for AMD clinical trial ➤ Topline data from Phase 2 trial evaluating suprachoroidal wet AMD treatment ➤ First patient dosed in Phase 1 DME treatment study ➤ Study: new gene variants contributing to glaucoma susceptibility identified ➤ ASCRS news and events
➤ FDA approves updated femtosecond laser for refractive surgery ➤ Positive topline results from Phase 3, first-in-class dry eye disease studies ➤ Rare Disease Designation granted for investigational gene therapy ➤ Positive interim data for investigational Stargardt disease treatment ➤ First patient dosed in Phase 2 trial for DME treatment ➤ Research program established to investigate whole eye transplant ➤ ASCRS news and events
➤ FDA approves new excimer laser technology ➤ Phase 3 trial to evaluate phentolamine for treatment of decreased visual acuity ➤ Phase 2 trial of investigational dry eye drug sees effect on signs and symptoms ➤ Study has new findings to promote corneal healing ➤ ASCRS news and events
➤ ASCRS advocacy helps protect MIGS coverage ➤ FDA approves generic loteprednol etabonate ophthalmic suspension ➤ Orphan Drug Designation granted for corneal endothelial cell substitute ➤ Positive results in Phase 2 clinical trial for contact lens discomfort ➤ First patient visits ➤ Acquisition news ➤ Complimentary access to video journal ➤ ASCRS news and events
➤ Positive topline results in Phase 2a trial for treatment of MGD in patients with Demodex ➤ First patient visit in Phase 2b trial evaluating anti-TNFα for dry eye disease ➤ Smart contact lens makes progress ➤ Asset transition ➤ ASCRS news and events
➤ Primary, secondary endpoints met in Phase 2 wet AMD trial ➤ Modifications made to investigational glaucoma treatment device ➤ Positive Phase 1/2 data from clinical trial for treatment of Leber congenital amaurosis ➤ Results from first-in-human study of siRNA treatment for AMD ➤ Possibility of a minimally invasive approach for treating AMD ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.